Preclinical and clinical overview of terpenes in the treatment of urolithiasis

European Urology, Supplements

Volumn 9, Issue 12, 2010, Pages 814-818

  Bach, Thorsten ^a  

^a ASKLEPIOS HOSPITAL BARMBEK   (Germany)

Author keywords

Expulsive therapy; Medical treatment; Rowatinex; Shock wave lithotripsy; Terpenes; Urolithiasis

Indexed keywords

1,3,3 TRIMETHYL 2 NORCAMPHANONE; ANETHOLE; ANTIUROLITHIASIS AGENT; BORNEOL; CALCIUM CHANNEL BLOCKING AGENT; CAMPHENE; CINEOLE; DICLOFENAC; PINENE; PLACEBO; ROWATINEX; SPASMOLYTIC AGENT; TAMSULOSIN; TERPENE; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANTIBACTERIAL ACTIVITY; DIURETIC ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRACORPOREAL LITHOTRIPSY; GERMANY; HUMAN; MEDICAL LITERATURE; NAUSEA; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; URETER STONE; UROLITHIASIS;

EID: 78650746408     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2010.11.009     Document Type: Review

References (26)

1. Preminger G.M., Tiselius H.-G., Assimos D.G., et al. 2007 guideline for the management of ureteral calculi. Eur Urol 2007, 52:1610-1631.
2. Hollingsworth J.M., Rogers M.A., Kaufman S.R., et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006, 68:1171-1179.
3. Micali S., Grande M., Sighinolfi M.C., De Stefani S., Bianchi G. Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofen, after shock wave lithotripsy of ureteral stones. Urol Res 2007, 5:133-137.
4. Sowter S.J. Tolley DA The management of ureteric colic. Curr Opin Urol 2006, 6:71-76.
5. Porpiglia F., Ghignone G., Fiori C., Fontana D., Scarpa R.M. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004, 72:568-571.
6. Losek R.L., Mauro L.S. Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi. Ann Pharmacother 2008, 42:692-697.
7. Arrabal-Martin M., Fernandez-Rodriguez A., Arrabal-Polo M.A., Garcia-Ruiz M.J., Zuluaga-Gomez A. Extracorporal renal lithotripsy: evaluation of residual lithiasis treated with thiazides. Urology 2006, 68:956-959.
8. Beach M.A., Mauro L.S. Pharmacological expulsive treatment of ureteral calculi. Ann Pharmacother 2006, 40:1361-1368.
9. Engelstein D., Kahan E., Servadio C. Rowatinex for the treatment of ureterolithiasis. J Urol (Paris) 1992, 98:98-100.
10. Mukamel E., Engelstein D., Simon D., Servadio C. The value of Rowatinex in the treatment of ureterolithiasis. J Urol (Paris) 1987, 93:31-33.
11. Al-Mosawi A.J. Essential oil terpenes: adjunctive role in the management of childhood urolithiasis. J Med Food 2010, 13:247-250.
12. Hasegawa M., Toda T., Hara N., Doi S. Effect of the terpen combination in experimental calcium oxalat nephrolithiasis. Nishi Nihon Hinyo 1982, 44:213-220.
13. Hasegawa M., Toda T., Kitada H., et al. Effect of the terpen drug Rowatin on experimental urolithiasis. Basic Pharm Ther 1979, 7:3865-3875.
14. Cipriani P., Mancini C. Microbiological activity of a terpen product used in the treatment of urinary diseases. Gaz Int Med e Chir 1972, 77.
15. Horvath N. The use and effect of the terpenes in nephrolithiasis. Ärztliche Praxis 1963, 15:1521-1528.
16. Lorenz T., Lorenz J., Szczudlowska-Chelstowska G. Observations on the treatment of urolithiasis with essential oils. Pol Tyg Lek 1961, 16:1608-1612.
17. Stern P., Vukcevic S. On influencing of nephrocalcinosis in rats. Z Urol 1960, 53:59-63.
18. Geinitz W. The prevention of urinary calculi by Rowatinex in animal experiments. Munch Med Wochenschr 1956, 98:895-897.
19. Quick A.J. Quantitative studies of β-oxidation. The metabolism of conjugated glycuronic acids. J Bio Chem 1928, 80:535-541.
20. Kohlert C., Rensen van I., März R., Schindler G., Graefe E.U., Veit M. Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans. Planta Med 2000, 66:495-505.
21. Asai J., Tsay Y.C., Miyake K., Makino M. Treatment of urolithiasis with a terpene preparation, Rowatinex 1959, Department of Urology, Nagoya University, Nagoya, Japan.
22. Hammer O., Rothe K. On the conservative therapy of nephrolithiasis. Med Welt 1961, 31:1576-1581.
23. Siller G., Kottasz S., Palfi Z. Effect of Rowatinex capsules on the stone fragments formed by extracorporal shock-wave lithotripsy. Magyar Urologia 1998, 10:139-146.
24. Aldemir M, Ücgül YE, Kayigil Ö. Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study. Int Urol Nephrol. In press.
25. Djaladat H., Mahouri K., Khalifeh Shooshtary F., Ahmadieh A. Effect of Rowatinex on calculus clearance after extracorporal shock wave lithotripsy. Urol J 2009, 6:9-13.
26. ®): results of a placebo-controlled, randomized trial. Eur Urol Suppl. 2010, 9:819-825.